Literature DB >> 9781442

Erythropoietin-producing renal cell carcinoma arising from acquired cystic disease of the kidney.

T Hanada1, H Mimata, H Ohno, N Nasu, M Nakagawa, Y Nomura.   

Abstract

A 49-year-old woman had been on hemodialysis for 18 years. She presented with left back pain and macrohematuria. Radiologic studies demonstrated a left renal tumor with acquired cystic disease of the kidney. Her serum erythropoietin (EPO) level was 78.4 U/L despite no history of EPO supplementation. Left radical nephrectomy was performed. Pathologic examination revealed EPO-producing renal cell carcinoma. After surgery, the patient's serum EPO level decreased markedly to 15.1 U/L. The measurement of serum EPO levels may be useful for detecting and monitoring a recurrence of renal cell carcinoma with acquired cystic disease of the kidney in patients on long-term hemodialysis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781442     DOI: 10.1111/j.1442-2042.1998.tb00397.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  4 in total

1.  Idiopathic erythrocytosis in a patient on chronic hemodialysis.

Authors:  Dong Hyun Lee; Ji Hye Min; Sang Byung Bae; Hyo Wook Gil; Jong Oh Yang; Eun Young Lee; Sae Yong Hong
Journal:  Kidney Res Clin Pract       Date:  2014-11-27

2.  Erythropoietin production in renal cell carcinoma and renal cysts in autosomal dominant polycystic kidney disease in a chronic dialysis patient with polycythemia: A case report.

Authors:  Keiichi Ito; Takako Asano; Susumu Tominaga; Hidehiko Yoshii; Harutake Sawazaki; Tomohiko Asano
Journal:  Oncol Lett       Date:  2014-08-21       Impact factor: 2.967

3.  Polycythemia vera as a presentation of renal angiomyolipoma: a case report.

Authors:  Ming-Shyan Lin; Yu-Shin Hung; Hsueh-Hua Wu; Ming-Chung Kuo; Tzu-Fang Shiu; Cheng-Keng Chuang; Lee-Yung Shih; Pao-Hsien Chu
Journal:  J Med Case Rep       Date:  2009-10-31

Review 4.  Functional significance of erythropoietin in renal cell carcinoma.

Authors:  Christudas Morais; David W Johnson; David A Vesey; Glenda C Gobe
Journal:  BMC Cancer       Date:  2013-01-10       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.